Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
BLT | Good results ? | 16/02/25 | 4 | 2.2K | |||
|
|||||||
BLT | Benitec Biopharma's Oculopharyngeal Muscular Dystrophy ... | 14/02/24 | 1 | 1.1K | |||
|
|||||||
BLT | Letter received - YOUR IMMEDIATE ACTION IS REQUIRED PER DELAWARE UNCLAIMED PROPERTY LAWS | 11/12/23 | 2 | 1.9K | |||
|
|||||||
BLT | NEO Compensation | 03/12/23 | 7 | 4.5K | |||
|
|||||||
BLT | OPMD update | 04/07/23 | 5 | 2.3K | |||
|
|||||||
BLT | Morgan Stanley increases their stake to 5.2% | 21/10/21 | 1 | 1.7K | |||
|
|||||||
BLT | CSL and RNAi | 07/03/21 | 21 | 258K | |||
|
|||||||
BLT | Ann: Benitec Provides Update on BB-301 OPMD Program | 04/03/21 | 66 | 27K | |||
|
See All Discussions